Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing rotigotine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 4mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rotigotine 2mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rotigotine 6mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rotigotine-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 250 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 250 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only rotigotine in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 125 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 125 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Rotigotine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |